Tuesday - 10th May 2022 (TimeZone BST)

  • 09:30
  • Welcome Address & Platform Orientation - Orientation will focus on how to access and navigate the virtual conference platform for Live Sessions & Interactive Networking

  • 09:40
  • Chairperson’s opening remarks


    Gabor Purman

    Gabor Purman Scientific Solutions Director
    NexGen Healthcare Communications

Innovation in Pharma

  • 09:50
  • From product centricity to customer centricity : How AI is transforming commercial organization ?

      Watch Session   Presentation
    Florent Hassen

    Florent Hassen Global Data Science & Artificial Intelligence Lead
    F. Hoffmann-La Roche

  • 10:15
  • Executives Discussion and Debate: How AI and Machine Learning is driving value for Global Pharma

    • Innovation in Big-Pharma
    • AI enabled business models in R&D
    • Achieving full potential of AI to boost Drug Discovery and Development
    • AI has the capacity to radically reduce the uncertainty in both early and late-stage drug discovery and development
      Watch Session
    Gabor Purman

    Gabor Purman Scientific Solutions Director
    NexGen Healthcare Communications

    Thomas Ehmer

    Thomas Ehmer Business Technologies R&D Science and Technology - Innovation Incubator
    Merck Group

    Mohamed-Ramzi Temanni

    Mohamed-Ramzi Temanni Scientific Director, Head of France AI & Genomics
    Janssen Pharmaceuticals

    Bhupathy Alagiriswamy

    Bhupathy Alagiriswamy Local Study Associate Director
    AstraZeneca

  • 10:50
  • Redefining research: how machine reading finds you answers - not documents

    • How today's solutions can't cope with the volume of scientific data
    • How machine reading delivers human-like extraction and comprehension across millions of documents
    • How Causaly's knowledge graph allows users to ask complex questions for target identification across all therapeutic areas
      Watch Session   Presentation
    Artur Saudabayev

    Artur Saudabayev Co-Founder and CTO
    Causaly

ML and AI based Drug Discovery

  • 11:20
  • Accelerating scientific discovery: Exploring early drug discovery through Artificial intelligence

      Watch Session
    Christos Varsakelis

    Christos Varsakelis Team Lead AI/ML Early Drug Discovery, In Silico Discovery & External Innovation
    Janssen Pharmaceutical

  • 11:45
  • Precision Medicine powered by AI: therapeutic target selection

    • OncoSNIPER, a platform to identify and validate new therapeutic targets
    • From Data generation to experimental validation
    • Hybrid Artificial Intelligence
      Watch Session   Presentation
    Stéphane Gerart

    Stéphane Gerart Chief Information Officer | Head of Artificial Intelligence Business Unit
    Oncodesign

  • 12:10
  • Accelerating drug discovery through quantum-computing

    • Analysing larger-scale molecules  
    • Algorithmic developments in quantum machine learning
    • Offer better insights and the potential to help advance drug discovery
      Watch Session
    Thomas Ehmer

    Thomas Ehmer Business Technologies R&D Science and Technology - Innovation Incubator
    Merck Group

  • 12:35
  • Virtual Luncheon & Networking - Visit Exhibitor Booths & Network with your peers in our Lounge (Face to Face Video Chats)

     

                

  • 13:35
  • A path forward to Prescriptive Decision Making

      Watch Session
    Ramila Peiris

    Ramila Peiris Director - Head of Data Science
    Sanofi Pasteur

  • 14:00
  • Abbvie Case Study: Machine intelligence approach for drug discovery

      Watch Session
    Abhishek Pandey

    Abhishek Pandey Group Lead: Pharma discovery
    Abbvie

Genomics and Precision Medicine

  • 14:25
  • Enabling precision medicine with integrated genomic and clinical data

    • Transforming the precision research value chain
    • How do we implement Precision Medicine?
    • How does it affect the ecosystem of healthcare?
    • Future of genomics and precision medicine
      Watch Session
    Zisis Kozlakidisor

    Zisis Kozlakidisor Head, Laboratory Services and Biobank Groups, IARC - International Agency for Research on Cancer
    World Health Organization

  • 14:50
  • BioRels – A single data ecosystem for Genetic Medicines

      Watch Session
    Jérémy Desaphy

    Jérémy Desaphy Director Scientific data and informatics - Genetic Medicine
    Eli Lilly and Company

  • 15:15
  • Exhibitor Session

  • 15:30
  • Search and text mining on FDA and EMA drug labels

      Watch Session
    Peter Henstock

    Peter Henstock Machine Learning & AI Technical Lead
    Pfizer

    David Edelen

    David Edelen Directory, Regulatory Solutions
    Pfizer

  • 16:00
  • Visit Virtual Exhibitor Booths/Speed Networking at our Exclusive Lounge (Face to Face Video chat with Exhibitors and other attendees)

     

         

Data Science, Big Data & Informatics

  • 16:20
  • Harnessing the Power of Data Science – How to Design a Platform that can Deliver on your Dreams

     

    Key aspects of establishing a successful data science platform for a Pharma company

    • Strategic considerations
    • Bayer’s cross-divisional data science platform
    • Example use cases leveraging the platform
      Watch Session
    Stefan Schmitz

    Stefan Schmitz Lead Product Owner Data Science Platform
    Bayer

  • 16:45
  • Natural Language Processing applications in Healthcare

    • How can NLP support healthcare industry?
    • Utilizing NLP in future clinical research
    • Challenges and Limitations of NLP
      Watch Session
    Mohamed Sharaf

    Mohamed Sharaf EMEA Medical Program Lead (Immunology)
    Janssen Europe, Middle East & Africa (EMEA)

  • 17:10
  • AI and Machine Learning for Next Generation of Biopharmaceuticals

      Watch Session
    Per Jr. Greisen

    Per Jr. Greisen Director for Computational Drug Discovery
    Novo Nordisk

  • 17:35
  • Digital Transformation in Pharma

      Watch Session
    Shruthi Bharadwaj

    Shruthi Bharadwaj Head, Science and Technology Intelligence
    Sanofi

  • 18:00
  • Implementation and relevance of FAIR data principles in Pharmaceutical R&D

    • Improving the efficiency and effectiveness by implementing the FAIR guiding principles for scientific data
    • Tools enabling FAIR data
    • Fair as a machine learning enabler
    • Benefits of FAIR in pharma

    Chuangkee Ong (Ck)

    Chuangkee Ong (Ck) Associate Director, Lead Information Architecture
    AstraZeneca

  • 18:25
  • Chairperson's Closing remarks


    Gabor Purman

    Gabor Purman Scientific Solutions Director
    NexGen Healthcare Communications

  • 18:35
  • Networking Drinks Session


Wednesday - 11th May 2022 (TimeZone BST)

  • 09:30
  • Welcome Address & Platform Orientation - Orientation will focus on how to access and navigate the virtual conference platform for Live Sessions & Interactive Networking

  • 09:50
  • Chairperson’s opening remarks


    Gabor Purman

    Gabor Purman Scientific Solutions Director
    NexGen Healthcare Communications

  • 10:00
  • Pharma Business Process and Data Sustainable Digital Transformation using Semantic Knowledge

      Watch Session
    Cedric Berger

    Cedric Berger Head of Knowledge Extraction and Integration
    Roche

  • 10:25
  • Precision medicine 2.0 - Importance of patient input and insights

      Watch Session
    Thomas Hach

    Thomas Hach Executive Director Patient Engagement Cardiovascular, Renal & Metabolism
    Novartis

  • 11:15
  • Potential impact of Digital Health in Pharma

    • Strategies for efficient collaboration
    • Digital health is proving to be a valuable asset for the pharma industry
    • Intersection of health-care and pharma are together transforming customer journey
    • Identifying others areas that need to be looked at
    • Innovation is key to the future
      Watch Session   Presentation
    Mark Milton-Edwards

    Mark Milton-Edwards Head of Health Solutions - Digital Health
    Teva Pharmaceuticals

  • 11:40
  • Pivotal role of Data Integration in enabling decision making for non-data scientists in early drug discovery

    • Integrating data from distinct sources and leverage predictive analytics to drive informed, realtime decisions
    • Multi-parameter optimization to avoid over-optimization
    • Role of data integration and analytics to highlight data gaps
    • Implementing end-to-end data integration
      Watch Session
    Nikolaus Stiefl

    Nikolaus Stiefl Director Data Science
    Novartis

  • 12:05
  • Open Innovation & AI Development through a collaborative ecosystem approach

      Watch Session
    Simon Philip Rost

    Simon Philip Rost Marketing Director EMEA
    GE Healthcare

  • 12:30
  • Virtual Luncheon & Networking - Visit Exhibitor Booths & Network with your peers in our Lounge (Face to Face Video Chats)

     

                

Real World Data, Real World Evidence & Data Integration

  • 13:10
  • How the Biopharmaceutical market can leverage Cloud Computing and AI to accelerate Drug Discovery and Time to Market

      Watch Session   Presentation
    Joe Miles

    Joe Miles Managing Director: Healthcare & Life Sciences Industries
    Google Cloud (NJ)

  • 13:35
  • Real World Evidence model for assessing new drugs - Enhancing Real World Data Environment

    • How RWE model can be used in R&D to accelerate new product developments?
    • Integrated evidence development model
    • Building an effective RWE based capabilities system
    • Advantages of implementing AI and ML
      Watch Session   Presentation
    Eric Sarpong

    Eric Sarpong Director, Real-World Data Analytics and Innovation
    Merck

  • 14:00
  • Real-World Data, Big Data and Artificial Intelligence: Recent Development and Emerging Trends in the European Union

    • RWE is increasingly of importance in the regulatory context for to EU for advancing care through end-to-end applications across the entire product cycle.
    •  RWD helps better understand the impact of various disease on vulnerable populations, as well as develop tailored telemedicine and care plans.
    •  This talk provides an overview of integrating RWD, big data and AI into healthcare is highly relevant for next generation clinical development and medical affairs, especially in regulatory settings.
      Watch Session   Presentation
    Kelly H. Zou

    Kelly H. Zou Head of Global Medical Analytics and Real World Evidence
    Viatris

Digital Health in Pharma & Collaboration

  • 14:25
  • Remote Vision Monitoring for Retinal Diseases: A Case Study

      Watch Session   Presentation
    Leslie Anne Fendt

    Leslie Anne Fendt Global Integrated Solutions Product Leader - Digital Health
    Roche

  • 14:50
  • Big data in Pharma: How Big Data and externalization strategy impacts Drug development.

      Watch Session
    Shrividya Iyer

    Shrividya Iyer Executive Director, Oncology Global Real World Evidence (RWE) & US HEOR
    Eisai US

  • 15:15
  • Transforming clinical trials failed drugs into stratified & repurposed medicine with AI

      Watch Session
    David Camacho-Trujillo

    David Camacho-Trujillo CEO
    GeneHolistics

  • 15:40
  • Visit Virtual Exhibitor Booths/Speed Networking at our Exclusive Lounge (Face to Face Video chat with Exhibitors and other attendees)

     

         

  • 16:00
  • The convergence of Digital Therapeutics and Pharma in Digital Health

    • Pharma-digital therapeutic alliances
    • Making treatment more accessible
    • How to fit it into the pharmaceutical workflow
      Watch Session
    Oksana Andreiuk

    Oksana Andreiuk Digital and Data Innovation Lead
    Abbvie

  • 16:25
  • Realizing a new paradigm for drug discovery and development: the intersection of genomic, digital and data sciences

      Watch Session
    Nadeem Sarwar

    Nadeem Sarwar Global Head of Genomic Strategies & Digital Therapeutics (DTx) Strategies
    Eisai EMEA

  • 16:50
  • Panel Discussion: Pharma-Health Collaboration: The Future of Drug Discovery

    • Why is it important for pharma and healthcare to work together?
    • How will digitization help bring patients on board?
    • A partnership can turn out better products in one or two decades
    • Pharma companies need to be more open with sharing data in order to create a pipeline of drugs
      Watch Session
    Gabor Purman

    Gabor Purman Scientific Solutions Director
    NexGen Healthcare Communications

    Sahab Aslam

    Sahab Aslam Associate Director, Global Data Science & Analytics Products
    MSD

    Lina Titievsky

    Lina Titievsky RWE Team Lead, Vertex Cell and Gene Therapies
    Vertex

    David Camacho-Trujillo

    David Camacho-Trujillo CEO
    GeneHolistics

  • 17:20
  • Insights from pharma, provider & payer

      Watch Session
    Jin Lee

    Jin Lee Director of Digital Health, Rx+
    Astellas Pharma Inc

  • 17:45
  • Chair Person's Closing remarks


    Gabor Purman

    Gabor Purman Scientific Solutions Director
    NexGen Healthcare Communications


Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now